A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, Chris H, O'Connor, Paul W, Havrdova, Eva, Hutchinson, Michael, Kappos, Ludwig, Miller, David H, Phillips, J. Theodore, Lublin, Fred D, Giovannoni, Gavin, Wajgt, Andrzej, Toal, Martin, Lynn, Frances, Panzara, Michael A, Sandrock, Alfred W
Published in The New England journal of medicine (02.03.2006)
Published in The New England journal of medicine (02.03.2006)
Get full text
Journal Article
Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study
Cortes, Jorge, Prof, Feldman, Eric, Prof, Yee, Karen, MD, Rizzieri, David, MD, Advani, Anjali S, MD, Charman, Anthony, PhD, Spruyt, Richard, BSc, Toal, Martin, FFPM, Kantarjian, Hagop, Prof
Published in The lancet oncology (01.04.2013)
Published in The lancet oncology (01.04.2013)
Get full text
Journal Article
Phase 1 and preclinical profiling of ESM‐HDAC391, a myeloid‐targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia
Furze, Rebecca C., Molnar, Judit, Parr, Nigel J., Ahmad, Faiz, Henry, Yvette, Howe, David, Singh, Rajendra, Toal, Martin, Bassil, Anna K., Bernard, Sharon G., Davis, Robert P., Gibson, Adele, Maller, N. Claire, Sharp, Catriona, Tough, David F., Prinjha, Rab K., Lewis, Huw D.
Published in British journal of clinical pharmacology (01.12.2022)
Published in British journal of clinical pharmacology (01.12.2022)
Get full text
Journal Article
A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors
BANERJI, Udai, VAN DOORN, Leni, HOOFTMAN, Leon, DE BONO, Johann Sebastian, VERWEIJ, Jaap, ESKENS, Ferry Alm, PAPADATOS-PASTOS, Dionysis, KRISTELEIT, Rebecca, DEBNAM, Phillip, TALL, Matthew, STEWART, Adam, RAYNAUD, Florence, DAWN GARRETT, Michelle, TOAL, Martin
Published in Clinical cancer research (01.05.2012)
Published in Clinical cancer research (01.05.2012)
Get full text
Journal Article
A phase I first‐in‐human study with tefinostat – a monocyte/macrophage targeted histone deacetylase inhibitor – in patients with advanced haematological malignancies
Ossenkoppele, Gert J., Lowenberg, Bob, Zachee, Pierre, Vey, Norbert, Breems, Dimitri, Loosdrecht, Arjan A., Davidson, Alan H., Wells, Graham, Needham, Lindsey, Bawden, Lindsay, Toal, Martin, Hooftman, Leon, Debnam, Phillip M.
Published in British journal of haematology (01.07.2013)
Published in British journal of haematology (01.07.2013)
Get full text
Journal Article
Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukeaemia (OPAL): a randomized open-label phase 2 study
Cortes, Jorge, Feldman, Eric, Yee, Karen, Rizzieri, David, Advani, Anjali S., Charman, Anthony, Spruyt, Richard, Toal, Martin, Kantarjian, Hagop
Published in The lancet oncology (28.02.2013)
Published in The lancet oncology (28.02.2013)
Get full text
Journal Article
Results of the OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia
Cortes, Jorge E., Feldman, Eric J, Yee, Karen, Rizzieri, David A., Advani, Anjali S., Charman, Anthony, Toal, Martin J., Kantarjian, Hagop M.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
An Integrated Efficacy and Safety Analysis of Phase 1/2 Studies of Tosedostat, a Novel Aminopeptidase Inhibitor, as Monotherapy for Hematological Malignancies
Myint, Han, Campbell, Mary, Caldwell, Susan E, Wang, Lixia, Spuryt, Richard, Toal, Martin, Singer, Jack W
Published in Clinical lymphoma, myeloma and leukemia (01.09.2014)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2014)
Get full text
Journal Article
509 The OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia
Cortes, Jorge, Feldman, Eric, Yee, Karen, Toal, Martin, Richardson, Alison, Charman, Anthony, Flores, Nico
Published in Clinical lymphoma, myeloma and leukemia (01.06.2011)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2011)
Get full text
Journal Article
Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis
Herndon, Robert M, Rudick, Richard A, Munschauer, Frederick E, Mass, Michele K, Salazar, Andres M, Coats, Michael E, Labutta, Robert, Richert, John R, Cohan, Stanley L, Genain, Claude, Goodkin, Donald, Toal, Martin, Riester, Katherine
Published in Multiple sclerosis (01.08.2005)
Published in Multiple sclerosis (01.08.2005)
Get full text
Journal Article
Eight-year immunogenicity and safety of interferon beta-la-avonex® treatment in patients with multiple sclerosis
HERNDON, Robert M, RUDICK, Richard A, GOODKIN, Donald, TOAL, Martin, RIESTER, Katherine, MUNSCHAUER, Frederick E, MASS, Michele K, SALAZAR, Andres M, COATS, Michael E, LABUTTA, Robert, RICHERT, John R, COHAN, Stanley L, GENAIN, Claude
Published in Multiple sclerosis (2005)
Get full text
Published in Multiple sclerosis (2005)
Journal Article